VACCINES DAMAGES  (English) 
Il Thiomersal dei vaccini produce danni anche gravi
Metalli tossici
Danni al sistema enzimatico da Vaccini e metalli 
By Giusy Arcidiacono (CT) - arcidiaconogiusy@hotmail.com - Perito Commerciale - chimico
Sindrome della permeabilita' intestinale ed autismo
Metalli tossici dei vaccini = Autismo vedi: PDF -  dott. M. Proietti
Il Thimerosal dei vaccini distrugge e/o altera la flora intestinale essendo una sostanza altamente tossica
Uno studio in inglese dimostra, che bambini NON vaccinati sono più sani che i bambini vaccinati
http://www.naturalblaze.com/2014/02/studies-prove-without-doubt-that.html
Ecco il recente studio che ha coinvolto più di 17.000 bambini fino a 19 anni
Questo studio-indagine attualmente in corso è stato avviato dall’omeopata Andreas Bachmair.
La scomparsa delle malattie infettive NON e' dovuta ai vaccini ! (Francais)
Bibliografia aggiuntiva:
http://treasoncast.com/2014/04/05/anti-vaccination-peer-reviewd-research-list/
 

MERCK PRESS RELEASE ON CHICKENPOX - vedi: Vaccins Dangereux (Francais)

Michael Belkin wrote:
Today, five years after its licensure by the FDA, the varicella (chickenpox) vaccine is recommended by all major vaccine policy-making organizations in the U.S., and is required for school and/or day care entry in 22 states, with others pending.
Yet, the national vaccination rate reported for chickenpox in 1998 was only 43 percent, far below that of other childhood vaccine-preventable diseases. ``The chickenpox vaccine has been shown to be just as effective in the field as it was in clinical trials, yet many children in the US remain unvaccinated,'' said Barbara Watson, MD, Pediatric Infectious Disease Specialist at Albert Einstein Medical Center, Philadelphia. ``We need to increase coverage to the point where all of our children are protected against this highly infectious disease that can have potentially serious consequences.''
http://biz.yahoo.com/prnews/000317/pa_merck_c_1.html

"My "agenda" is to tell the truth. Like the fact that, according to Centers for Disease Control (CDC) statistics, as many as 800,000 vaccine induced injuries have occurred every year in the United States since 1990."
By Leonard Horowitz

VACCINI OMICIDIO di MASSA
 

The US Federal Government's National Vaccine Injury Compensation Program (NVICP) has paid out over 724.4 million dollars to parents of vaccine injured and killed children, in taxpayer dollars.

The NVICP has received over 5000 petitions since 1988, including over 700 for vaccine-related deaths, and there are still over 2800 total death and injury cases pending that may take years to resolve (NVICP, Health Resources and Services Administration).

"The carnage caused by vaccinations has become so immense, and the outcry from the grieving parents so intense, that the government has set up a national compensation program in order to smooth everything over and to protect drug companies and doctors from law suits. You, of course, pay for this insurance for drug companies and doctors by the cost being added to the price  of the vaccines. In 1982, the vaccines cost $23 per child. By 1992, the cost had risen to $244--an increase of over 1,000 percent !

This devastation of our children by our own doctors and public-health departments has been so colossal that over $249 million has been awarded for vaccine-caused injuries and deaths, and the program is now bankrupt.Thousands of cases are pending that will recieve nothing--the pay window has been slammed shut.

Even if you got lucky and recieved "compensation," will that make up for your child's permanent paralysis ("Guillain-Barre syndrome"), blindness ("idiopathic macular degeneration"), mental deficiency ("learning disorder"), or incoordination ("tardive dyskinesia")? Will all those phoney diagnoses used to cover up the real diagnosis help? Will a million dollars make everything okay? Ten million?"---William Douglas MD

Hassan W, Oldham R. Reiter’s syndrome and reactive arthritis in health care workers after vaccination. British Medical Journal 1994; 309: 94

MECHANISMS OF VACCINATION SEQUELAE by Teresa Binstock Researcher in Developmental and Behavioral Neuroanatomy  http://www.jorsm.com/~binstock/vacc-let.htm     At Whale

"Role of Immunogenetics in the Diagnosis of Postvaccinal CNS Pathology," Massimo Montinari, et al., Department of Pediatric Surgery, University of Bari, Italy, presented May 9, 1996 - text available:

 http://www.healthy.net/library/articles/coulter/biochem.htm or www.mednat.org

after thirty children were found to have signs of central nervous system and genetic damage following vaccination, the authors remark, "A study of the disease associated with genes of the HLA system has shown that this genetic complex can be responsible for am particular genetic susceptibility, predisposing to various diseases characterized predominantly by immune-system pathogenesis… results indicate that autoimmune pathology is more frequent in countries where vaccination is more widespread….." [A fuller description of this study will be found in "The attenuated virus--infectious or not?" below.]

 
MMR  VACCINE AND MENINGITIS LINK
Prominent medical journal just published a link between MMR vaccine and aseptic meningitis. Note how the authors carefully pay homage to the vaccine police in order to defend their careers against retaliation.
They say the issue is not that kids were injured by the vaccine, but that an outraged public might turn against the vaccine police. The same homage to the vaccine police was paid by authors in an earlier Lancet article that defended the now-discredited rotavirus vaccine, which needlessly injury numerous infants and even killed at least one.
Aseptic Meningitis Outbreak Linked to Widespread MMR Vaccination WESTPORT, Mar 03 An outbreak of aseptic meningitis in northeastern Brazil has been linked to a MMR vaccine used in a national immunization program.
Such outbreaks could have an impact on public health by influencing the public's willingness to undergo vaccination, researchers point out in the March 1st issue of the American Journal of Epidemiology.
"The issue is not simply whether or not a specific vaccine is associated with an adverse event, but the extent to which a specific vaccination strategy influences the visibility of the adverse event despite its confirmed relative rarity, and hence affects public confidence," writes a multicenter team of researchers led by Dr. Ines Dourado, of the Universidade Federal da Bahia in Salvador, Brazil. Dr. Dourado's team found that there was a sharp increase in the number of cases of aseptic meningitis 3 weeks after August 16, 1997, the highly publicized "national vaccination day" and the start of a mass MMR immunization campaign.
The number remained high over the following 3 weeks, then gradually declined, "returning to prevaccination figures by the 40th epidemiologic week." The researchers "conservatively estimated" that the risk of aseptic meningitis is about 1 in 14,000 MMR vaccine doses. Even though there was no virologic confirmation, the findings "suggest a causal link between the MMR mass immunization campaign and the aseptic meningitis outbreak," Dr. Dourado and associates state.
Am J Epidemiol 2000;151:524-530.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

REVAHB: FRENCH HEPATITIS B VACCINE VICTIM'S WEBSITE
Michael Belkin wrote:
This is the web site of Revahb (loosely translated "Reverb"), which is the French hepatitis B vaccine victim's association headed by a doctor who got a MS like disease from the hep B vaccine. Revahb hepatitis B vaccine victims are pursuing CRIMINAL charges in the French legal system against the perpetrators (not the kind of lawsuit that gets you a monetary settlement -- the kind that puts doctors and vaccine manufacturers behind bars).
Let's look forward to the day when those responsible for the US hep B vaccine plague of deaths, autism and neurological damage are convicted and in prison, not that it will help any of those who are dead or are the living victims. But if the perpetrators of the US hep B vaccine scandal are behind bars, other lives will surely be saved or not destroyed.
The Revahb website is (of course) in French. You can translate it (roughly and amusingly) if you don't speak French and get the general idea, using the AltaVista translator at http://babelfish.altavista.digital.com/cgi-bin/translate
(specify French to English and use the URL at the top of this page or
the URL of the section of the Revahb website you click on).
http://www.multimania.com/revahb/sommaire.htm

PETITION TO STOP PNEUMOCOCCAL VACCINE
Bart Classen wrote:
If you want to stop the following experiment please contact Congressman Dan Burton's staffer named Beth Clay at 202-225-5074 or email beth.clay@mail.house.gov
Please forward this to your friends. New `Tuskegee-Like Experiment' Planned with Pneumococcal Pneumonia
Vaccine, Reported by Classen Immunotherapies BALTIMORE, Feb. 18 /PRNewswire/ The following was released today by Classen Immunotherapies, Inc.:
The FDA cleared yesterday a controversial new pneumococcal pneumonia vaccine with questionable safety and a US government advisory panel is planning to selectively target black children and Native American children for immunization. This plan is being criticized for making children of certain racial minorities ``human guinea pigs''. It is possible that 1% or more of the children who receive the vaccine may develop insulin dependent diabetes or another autoimmune disease from
the vaccine.
This week the Center for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended that children under 2 receive the new pneumococcal vaccine but that black and Native American children age 2-5 be selectively targeted for immunization. This policy has come under criticism because the vaccine has never been properly tested for safety and the FDA has been told by an expert that the vaccine is expected to cause an epidemic of autoimmune disease.
The controversial vaccine is the conjugated 7-valent pneumococcal vaccine which is really a combination of 7 different vaccines, each to a separate strain of pneumococcal pneumonia bacteria. The vaccine is similar in structure to the already marketed hemophilus meningitis vaccine, a vaccine linked to large epidemics of insulin dependent diabetes.
Dr. J. Bart Classen, an immunologist at Classen Immunotherapies, published data in the British Medical Journal (BMJ 1999; 319:1133) supporting a causal relationship between the hemophilus vaccine and the development of insulin dependent diabetes. The vaccine has been incriminated in causing over 58 cases of insulin dependent diabetes per 100,000 children immunized in Finland. Dr. Classen told the FDA at a recent meeting that the 7 valent pneumococcal vaccine may be 7 times as toxic as the hemophilus vaccine, possibly causing an estimated 400 to 700 children to develop insulin dependent diabetes/100,000 children immunized. These cases of diabetes may not occur until 3.5 to 10 years following immunization.
The government's plan to selectively target black and Native Americans is likely to have the effect of genocide, 0.5% of children who receive this vaccine may develop insulin dependent diabetes from the vaccine and diabetes is just one of many life threatening autoimmune disease, states Classen. I believe the vaccine clearly should not have been approved by the FDA because it does not meet the criteria for approval based on US law.
Dr. Classen's research has been published in numerous journals and featured in national news reports. For the latest information on the effects of vaccines on insulin dependent diabetes and other autoimmune diseases visit the Vaccine Safety Website (http://vaccines.net)
Classen Immunotherapies, Inc.
6517 Montrose Avenue - Baltimore, MD 21212 U.S.A.- Tel: 410-377-4549 - Fax: 410-377-8526 -
Classen@vaccines.net - http://vaccines.net

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

CDC ON THIMEROSAL
National Immunization Program Thimerosal and Vaccine - Questions/Answers - July 15, 1999

Q 1. What is Thimerosal?
A. Thimerosal is a very effective preservative that contains mercury and has been used in some vaccines and other products since the 1930s. Thimerosal is the most widely used preservative in vaccines. The FDA estimates that it is used in more than 30 licensed vaccines and biologics. Mercury is excreted from the body over time.
Q 2. Why is Thimerosal used in vaccines?
A. Thimerosal is used as an extra safeguard against contamination. It may be used during processing or added to the final container to prevent contamination when multi-dose vials are opened. Before Thimerosal was marketed in the United States, a number of safety studies were conducted, first on animals and then on humans.
Thimerosal is an important preservative that protects vaccine against bacterial contamination.
It is very effective in killing bacteria used in several vaccines and in preventing bacterial contamination, particularly in opened multi-dose containers. Some but not all of the vaccines recommended routinely for children in the United States contain thimerosal. Disease outbreaks have occurred following contamination of multi-dose vaccine vials in the United States and from other countries. For example, in April, 1995, three infants died in India from toxic
shock syndrome after administration of contaminated measles vaccine at one health center.
Q3. Can all vaccines be made Thimerosal-free, or within accepted guidelines? If so, how quickly?
A. All vaccines either do not contain thimerosal or contain thimerosal within FDA guidelines. To further increase the margin of safety that already exists, clinicians can use the inherent flexibility in the current immunization schedule to fully vaccinate children and meet even the most conservative guidelines for cumulative mercury exposure. Clinicians and parents can take advantage of the flexibility within the existing schedule for infants born to Hepatitis B surface antigen (HbsAg)-negative women to postpone the first dose of hepatitis B vaccine from birth until two to six months of age when the infant is considerably larger.
Pre-term infants born to HBsAg-negative mothers should similarly receive hepatitis B vaccine, but ideally not until they reach term gestational age and a weight of at least 2.5 kilograms. Because of the substantial risk of disease, there is no change in the recommendations for infants of HbsAg-positive mothers or of mothers whose status is not known. Also, in populations where HbsAg screening of pregnant women is not routinely performed, vaccination of all infants at birth should be maintained, as is currently recommended.
Public Health Service agencies are working with private physician groups and vaccine
manufacturers to expedite the process to reduce or eliminate thimerosal from vaccines used in the United States.
Q4. What could happen if parents ignored recommendations to use thimerosal-containing vaccines during this transition period?
A. Children would be at very real risk from illnesses that can be prevented with safe and effective vaccinations.
High rates of vaccination led to declines of 95% to 100% in the occurrence of vaccine preventable diseases in the United States. Despite this, the pathogens responsible for most vaccine preventable diseases still circulate and rates of disease would increase if vaccine coverage dropped. For example, if vaccination coverage among infants dropped from 95% to 70%, an additional 2,500 cases of pertussis would be expected to occur.
Moreover, the risk of death from pertussis is greatest in young children. A second severe vaccine preventable disease among young children is Haemophilus influenzae type b (Hib).
Before vaccine was introduced, this pathogen was the leading cause of meningitis and other severe invasive infections among children; now cases of invasive Hib disease have virtually disappeared. If vaccination for Hib declined to 70%, 2,000 excess cases would occur with 1,200 cases of meningitis, resulting in about 100 deaths and 180 children who would suffer mental retardation and hearing loss.
Q5. Why isn&Mac226;t the federal government just recommending not using vaccines with thimerosal in them if there is concern?
A. Making vaccines safer and more effective is a constant goal for the federal government; and, that is the purpose of the action we&Mac226;re taking now. There is a significant safety margin incorporated into all acceptable mercury exposure limits. Furthermore, there are no data or evidence of any harm caused by the level of exposure that some children
may have encountered in following the existing immunization schedule. Today, we&Mac226;re discussing a minimal, if any, risk from minute levels of mercury-containing thimerosal versus the large and devastating risk of childhood diseases like bacterial meningitis and whooping cough if parents and physicians abandon vaccination during this transition period. Any missed vaccinations puts children at risk from disease.
Q6. How much mercury did my 6-month-old get in the last six months from vaccines? How dangerous is that?
A. Each dose of vaccine given your child met FDA requirements and should not be a concern to you now--your choice to vaccinate your baby was a sound one. The mercury levels being discussed are well within the safety margins; however, we are working toward further increasing the margin of safety that already exists. It is important that we limit the cumulative amount of mercury children are exposed to, but parents should not abandon vaccination as a means to do that.
Q7. If there are vaccines that are mercury-free, why shouldn't I just ask for those?
A. The American Academy of Pediatrics, the Advisory Committee on Immunization Practices for CDC and the Surgeon General all recommend that parents do not let their child miss a vaccination when safe and effective vaccines are available. Today, we are discussing a minimal, if any, risk from cumulative levels of mercury from some vaccines versus the large and devastating risk of childhood diseases like bacterial meningitis and whooping cough if parents and physicians abandon vaccination during this transition period.
Clinicians and parents can take advantage of the flexibility within the existing schedule for infants born to Hepatitis B surface antigen (HbsAg)-negative women to postpone the first dose of hepatitis B vaccine from birth until two to six months of age when the infant is considerably larger. Pre-term infants born to HBsAg-negative mothers should similarly receive hepatitis B vaccine, but ideally not until they reach term gestational age and a weight of at least 2.5 kilograms. Because of the substantial risk of disease, there is no change in the recommendations for infants of HbsAg-positive mothers or of mothers whose status is not known. Also, in populations where HbsAg screening of pregnant women is not routinely performed, vaccination of all infants at
birth should be maintained, as is currently recommended. Public Health Service agencies are working with private physician groups and vaccine manufacturers to expedite the process to reduce or eliminate thimerosal from vaccines used in the United States.
The American Academy of Pediatrics, the Advisory Committee on Immunization Practices for CDC and the U.S. Surgeon General want parents to be fully informed about children&Mac226;s vaccines and if you have questions or concerns, we encourage you to speak to your child&Mac226;s trusted health care provider.
Q8. I&Mac226;ve heard that children may be getting toxic levels of mercury from vaccines. Is that true?
A. Everyone is exposed to mercury, even in some foods and household products. As part of an ongoing assessment of mercury in the environment and in products, many agencies have developed guidelines for acceptable levels of mercury--levels many times below any amount known to cause harm.
Some children, depending on which vaccines they receive and the timing of those vaccines, are exposed to cumulative levels of mercury close to the safety ranges of guidelines. To further increase this
margin of safety, clinicians and parents can take advantage of the flexibility within the existing immunization schedule. It&Mac226;s important to understand that these highest acceptable levels include a "safety cushion" to take into account all the variables that people face in their exposures to mercury. No children are getting toxic levels of mercury from vaccines.
Q9. Are there vaccines available to prevent childhood diseases without exposing them to mercury?
A. Yes, although you may discover that these vaccines are not immediately available from your health care provider. The American Academy of Pediatrics, the Advisory Committee on Immunization Practices for CDC and the Surgeon General all recommend that parents do not let their child miss a vaccination when safe and effective vaccines are available. Today, we have a minimal, if any, risk from minute levels of mercury-containing thimerosal in some vaccines versus the large and devastating risk of childhood diseases like bacterial meningitis and whooping cough if parents and physicians abandon vaccination during this transition period.
The American Academy of Pediatrics, the Advisory Committee on Immunization Practices for CDC and the U.S. Surgeon General want parents to be fully informed about children&Mac226;s vaccines and if you have questions or concerns, we encourage you to speak to your child&Mac226;s trusted health care provider.
Q10. Why are the Public Health Service and AAP making these recommendations now?
A. Although mercury is found in the environment, in food and in household products, exposure to mercury is of concern and, when possible, should be avoided. The Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers agree that thimerosal should be reduced or eliminated in vaccines to make already safety vaccines even safer and to allow for new vaccines to be added to the schedule in the future. Some children, depending on which vaccines
they receive and the timing of those vaccines, are exposed to cumulative levels of mercury close to the safety ranges of guidelines. The mercury levels being discussed are within the safety margins; however, we are working toward further increasing the margin of safety that already exists. It is important that we limit the cumulative amount of mercury children are exposed to, but parents should not abandon vaccination as a means to do that.
Q11. Why are chemicals and other substances added to vaccines?
A. Many things in today's world, including foods and medicines, have chemicals added to them to prevent the growth of germs and reduce spoilage. Chemicals are added to vaccines for similar reasons, to inactivate a virus or bacteria and to stabilize it, helping to preserve the vaccine and prevent it from losing its potency over time.
Some additives are used in the production of vaccines. Vaccines may include suspending fluid (e.g., sterile water, saline, or fluids containing protein); preservatives and stabilizers (e.g., albumin, phenols, and glycine); and adjuvants or enhancers that help the vaccine improve its immunogenicity (ability to protect against disease).
Q12. I understand some people are sensitive to thimerosal and must avoid it. Do they have problems with thimerosal-containing vaccines?
A. Most patients do not develop reactions to thimerosal given as a component of vaccines even when they&Mac226;ve had a patch or intradermal tests for thimerosal that indicated hypersensitivity. Hypersensitivity to thimerosal usually consists of local, delayed reactions.
Q13. How can I find out what chemical additives are in specific vaccines?
A. Ask your health care provider or pharmacist for a copy of the vaccine package insert.
The package insert lists ingredients in the vaccine and discusses any known adverse reactions.
Q14. What is mercury?
A. Mercury is a metal, a chemical element found everywhere. As such, it is neither created, nor destroyed -- the same amount of mercury has existed since the earth was formed.
Two major forms of mercury exist in nature, an inorganic form (the mercury used in thermometers) and the organic form. Humans and wildlife are exposed to both, but the metallic mercury is quickly released from the body.
The organic form tends to accumulate in humans, and particularly in large predator fish.
Humans are usually exposed to organic mercury from eating fish which have accumulated it in their muscle tissue. Very high levels of mercury are toxic. Because mercury is everywhere, it is not possible to prevent all exposure to mercury.
Federal agencies, including the Agency for Toxic Substances and Disease
Registries and the Food Administration have established guidelines for levels of mercury exposure considered safe. In addition, uses and releases of mercury have been reduced very substantially in recent decades in the U.S. and most other industrialized countries.
Q15. Who is most vulnerable to mercury?
A. Two groups are most vulnerable to methyl mercury: the fetus and pregnant women. Premature babies are more vulnerable because they tend to be very small and their brain is not as developed as a full term baby. Children may be at higher risk of mercury exposure than are adults because they eat more per pound of body weight and because they may be inherently more sensitive than adults since their nervous systems are still developing.
The guidelines for mercury exposure are based on
amount of mercury per weight. This helps estimate reference level of exposure according to the person's weight.
Q16: What is the ATSDR level for mercury exposure?
A: The minimal risk level, or MRL, is 0.3 micrograms per kilograms of body weight per day (ug/kg/d) for ingestion of methylmercury. Mercury occurs in the environment in several forms: elemental, inorganic and organic mercury. Methylmercury is the most common form of organic mercury. People can be exposed to methylmercury by eating fish or shellfish that come from mercury-contaminated waters.
MRLs are health guidance values established by ATSDR and are intended for use by health assessors as screening tools when determining whether further evaluation of potential human exposure at hazardous waste sites is warranted. They are not intended for use in determining clean-up levels or for other regulatory purposes.
Q17: Why is this level different from EPA&Mac226;s?
A: Both agencies recognize Mercury as a neurotoxicant, a toxin which affects the nervous system of humans. Further, both agencies recognize that fetuses and women of reproductive age are among the groups at high risk from Mercury exposure. And, both agencies agree on the Minimal Risk Levels for exposure to two of the three forms of Mercury&Mac246;Elemental
Mercury by inhalation, and Inorganic Mercury by oral means. The agencies do differ in the MRL for Methyl Mercury (Organic Mercury).
The difference between the two agencies is extremely small. In the Toxicological Profile for Mercury, ATSDR uses exposure to 0.3 micrograms per kilogram of body weight per day as the Minimal Risk Level (the level at which scientists would not expect to see any adverse health effects, but at which they would see the need for additional investigation). EPA considers the level to be 0.1 micrograms/kilogram/day. A microgram is one millionth of a gram. A gram is 0.035 ounce.
Q18: What is the safety margin built into this level?
A:The ATSDR value (mrl of 03 mcg/kg/d) has a significant safety margin built into it. The value is approximately ten times below the highest exposure levels found in participants in the Seyschelles Study (a recent study evaluating individuals who were exposed to methyl mercury). Even at the highest exposure levels recorded in the Seyschelles Study, no participants experienced adverse health effects.
Q19: What happens if your exposure exceeds the recomended levels?
A: The nervous system is very sensitive to all forms of mercury. Methylmercury and metal vapors are more harmful than other forms, because more mercury in these forms reaches the brain. Exposure to high levels of metallic, inorganic, or organic mercury can permanently damage the brain, kidneys, and developing fetus. Effects on brain functioning may result in irritability, shyness, tremors, changes in vision or hearing, and memory problems.
Short-term exposure to high levels of metallic mercury vapors may cause effects including lung damage, nausea, vomiting, diarrhea, increases in blood pressure or heart rate, skin rashes, and eye irritation.
Q20: How can mercury affect children?
A: Very young children are more sensitive to mercury than adults. Mercury in the mother's body passes to the fetus and can pass to a nursing infant through breast milk. However, the benefits of breast feeding may be greater than the possible adverse effects of mercury in breast milk.
Mercury's harmful effects that may be passed from the mother to the developing fetus include brain damage, mental retardation, and lack of coordination, blindness, seizures, and an inability to speak. Children poisoned by mercury may develop problems of their nervous and digestive systems and kidney damage.
Q21. Which population groups have the highest levels of mercury?
A. Groups that tend to have higher exposure include subsistence and frequent recreational fishers, people of Asian origin, and some Native American groups.
The typical U.S. consumer eating fish from restaurants and grocery stores are not in danger of consuming harmful levels of mercury from fish and are not advised to limit fish consumption. Everyone is exposed to mercury, even in some foods and household products.
Q22. How can parents learn more about children&Mac226;s immunizations?
A. To learn more about children's immunizations, vaccinations, or baby shots from a CDC information specialist, please call CDC&Mac226;s National Immunization Information Hotline: 1-800-232-2522, for English, 1-800-232-0233, for Spanish.
Centers for Disease Control and Prevention - National Immunization Program

VACCINE DAMAGE
"My "agenda" is to tell the truth. Like the fact that, according to Centers for Disease Control (CDC) statistics, as many as 800,000 vaccine induced injuries have occurred every year in the United States since 1990."--Leonard Horowitz

The US Federal Government's National Vaccine Injury Compensation Program (NVICP) has paid out over 724.4 million dollars to parents of vaccine injured and killed children, in taxpayer dollars. The NVICP has received over 5000 petitions since 1988, including over 700 for vaccine-related deaths, and there are still over 2800 total death and injury cases pending that may take years to resolve (NVICP, Health Resources and Services Administration).

"The carnage caused by vaccinations has become so immense, and the outcry from the grieving parents so intense, that the government has set up a national compensation program in order to smooth everything over and to protect drug companies and doctors from law suits. You, of course, pay for this insurance for drug companies and doctors by the cost being added to the price  of the vaccines. In 1982, the vaccines cost $23 per child. By 1992, the cost had risen to $244--an increase of over 1,000 percent!
        This devastation of our children by our own doctors and public-health departments has been so colossal that over $249 million has been awarded for vaccine-caused injuries and deaths, and the program is now bankrupt.Thousands of cases are pending that will recieve nothing--the pay window has been slammed shut.
        Even if you got lucky and recieved "compensation," will that make up for your child's permanent paralysis ("Guillain-Barre syndrome"), blindness ("idiopathic macular degeneration"), mental deficiency ("learning disorder"), or incoordination ("tardive dyskinesia")? Will all those phoney diagnoses used to cover up the real diagnosis help? Will a million dollars make everything okay? Ten million?"---William Douglas MD

Hassan W, Oldham R. Reiter’s syndrome and reactive arthritis in health care workers after vaccination. British Medical Journal 1994; 309: 94

MECHANISMS OF VACCINATION SEQUELAE by Teresa Binstock Researcher in Developmental and Behavioral Neuroanatomy  http://www.jorsm.com/~binstock/vacc-let.htm     At Whale

"CONCLUSIONS: This clustering suggests that a causal relationship between measles vaccine and encephalopathy may exist as a rare complication of measles immunization." [Note regarding rarity: A huge number of vaccine reactions are never reported, and most of the thousands of vaccine injuries which are reported do not meet the current, very narrow VAERS/FDA criteria (a very few specific symptoms must occur within a very short timespan, in order for symptoms to be considered vaccine-related), and thus are not reported as vaccine-injury cases by government tabulators.
Serious vaccine complications thus are said to be "rare" in quoted statistics.
If independent research proves that the measles vaccine and PDD/autism are causally related, this kind of vaccine damage will inflate by thousands the cases of vaccine damage now on record. This tally, then, may be inflated further by the number of ADD/ADHD-diagnosed children with inflammatory bowel disorders, per the Georgetown University study cited I "Wakefield," below.]

"Measles-Mumps-Rubella (MMR) Vaccine as a Potential Cause of Encephalitis (Brain Inflammation) in Children," Harold E. Buttram, MD, Townsend Letters, December 1997

(available at http://www.mercola.com/issue5.htm ).

"Role of Immunogenetics in the Diagnosis of Postvaccinal CNS Pathology," Massimo Montinari, et al., Department of Pediatric Surgery, University of Bari, Italy, presented May 9, 1996
(text available http://www.healthy.net/library/articles/coulter/biochem.htm ): after thirty children were found to have signs of central nervous system and genetic damage following vaccination, the authors remark, "A study of the disease associated with genes of the HLA system has shown that this genetic complex can be responsible for am particular genetic susceptibility, predisposing to various diseases characterized predominantly by immune-system pathogenesis… results indicate that autoimmune pathology is more frequent in countries where vaccination is more widespread….." [A fuller description of this study will be found in "The attenuated virus--infectious or not?" below.]

(Pediatric Bulletin, http://home.coqui.net/myrna/virus.htm ).
"Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation" (Pediatrics, vol. 85, number 4 part 2, April 1990, pp. 698-704): "One concern with the use of [current HIB vaccines] was the suggestion that the incidence of invasive disease caused by H influenzae type b in the immediate period after immunization might be increased; this idea was supported by evidence from several sources." In one case-controlled study, 4 children were hospitalized for invasive disease within 1 week of immunization; the rate of invasive disease was 6.4 times greater than the background rate in unvaccinated children.

"Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans," Acta Virologica, vol. 42, number 3, June 1998, pp. 187-94: The oral poliovirus vaccine (OPV) sometimes occasions paralytic poliomyelitis in vaccine recipients and their susceptible contacts. Molecular biology studies of polioviruses from these patients demonstrate genomic modifications known or suspected to increase neurovirulence. The same genomic modifications have been identified in strains isolated from non-symptomatic vaccinees. Other neurologic complications such as meningitis, encephalitis, convulsions, transverse myelitis and Guillain-Barre Syndrome have also been associated with this vaccine.

"Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts" (Journal of Infectious Disease, vol. 176, no. 4, October 1997, pp. 1072-5): Twelve days after receiving an investigational Oka strain live attenuated varicella vaccine, a 38-year-old healthy woman developed a rash consisting of 30 scattered lesions. Sixteen days later, her two children also developed a rash. Varicella-zoster DNA obtained from the skin lesions was determined to be the vaccine type. "This case documents transmission of varicella vaccine type virus from a healthy vaccinee to susceptible household contacts…ongoing studies will define the frequency of this transmission."

"Live Virus Vaccines, High-Dose Steroids Don't Mix" (Pediatric News, cited November 28, 1998, via@access1.net, 10:49 a.m.): Dr. Larry K. Pickering, a member of the American Academy of Pediatrics' "Red Book Committee," was quoted following a meeting at the University of South Dakota, saying children receiving more than 2 mg/kg per day of systemic glucocorticoids should not be given live virus vaccines, due to the risk of disseminated infection from the vaccines. Killed virus vaccines do not present the same risk. [Note: steroids such as prednisone partially suppress the immune system.]

"Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program," Pediatrics, vol. 101, no. 3, Part 1, March 1998; pages 383-387: This study details cases wherein 48 children, ages 10 to 49 months, who had been so affected. Eight children died, and the remainder had mental regression and retardation, chronic seizures, motor and sensory deficits, and movement disorders. "CONCLUSIONS: This clustering suggests that a causal relationship between measles vaccine and encephalopathy may exist as a rare complication of measles immunization." [Note regarding rarity: A huge number of vaccine reactions are never reported, and most of the thousands of vaccine injuries which are reported do not meet the current, very narrow VAERS/FDA criteria (a very few specific symptoms must occur within a very short timespan, in order for symptoms to be considered vaccine-related), and thus are not reported as vaccine-injury cases by government tabulators. Serious vaccine complications thus are said to be "rare" in quoted statistics. If independent research proves that the measles vaccine and PDD/autism are causally related, this kind of vaccine damage will inflate by thousands the cases of vaccine damage now on record. This tally, then, may be inflated further by the number of ADD/ADHD-diagnosed children with inflammatory bowel disorders, per the Georgetown University study cited I "Wakefield," below.]

"Measles-Mumps-Rubella (MMR) Vaccine as a Potential Cause of Encephalitis (Brain Inflammation) in Children," Harold E. Buttram, MD, Townsend Letters, December 1997 (available at http://www.mercola.com/issue5.htm ).

T. Zecca, D. Grafino, et al., University of Medicine and Dentistry, New Jersey and Children's Hospital of New Jersey, Newark, "Elevated rubeola [measles] titers in autistic children linked to MMR vaccine" (abstract submitted to the National Institutes of Health, 1997-8; text available at http://webpages.netlink.co.nz/~ias/mmraut1.htm ): Rubeola (measles) titers were compared in autistic and normal children. Children diagnosed with autism revealed "a three fold increase" in their rubeola titers over expected normal range. "A Wilcoxon Kruskal Wallas test comparing 13 rubeola titers from normal children reveals a statistically significant P-value of 0.0050." The authors note that neurological sequelae following MMR are widely reported: "MMR therefore may play a role in the pathogenesis of Autism. The elevated titers of anti-measles antibodies in Autistic children may signify a chronic activation of the immune system against this neurotropic virus."

"Characterisation of poxviruses from sporadic human infections" (South African Medical Journal, vol. 72, no. 12, December 19, 1987, pp. 846-8): An orthopoxvirus was isolated from…a man in Natal who died in coma… Analysis of the viral DNA showed that it was a vaccinia virus, more closely related to the virus of South African smallpox vaccine than to other [natural] vaccinia viruses. DNA analysis also showed that an orthopoxvirus isolated from a sporadic case of severe pustular rash in Nigeria was a vaccinia virus closely related to the smallpox vaccine virus used there… [It was] suggested that some natural transmission of the virus had occurred…originat[ing] from the use of smallpox vaccine. No similar cases have been detected since smallpox vaccination was discontinued."

"Vaccinia virus persistence in a child against the background of immune deficiency" (J. Hyg. Epidemiol. Microbiol. Immunol., vol. 30, no. 2, 1986, pp. 177-83): " A young girl, vaccinated against smallpox 6 years before[,] suffered from a persistent vaccinia virus infection and a congenital skin disesase, i.e. epidermolysis bullosa. The virus was isolated from skin lesions at the vaccination site and remote sites and repeatedly from the blood… Examination of the child did not show any quantitative immune deficiency… The possible genesis of the virus persistence and the role of the virus in the clinical course of the disease are discussed." (A selected Medline [National Library of Medicine] "MESH" subject tracing for this report is "Smallpox Vaccine--adverse effects.")

"Polymerase chain reaction detection of the hemagglutinin gene from an attenuated measles vaccine strain in the peripheral mononuclear cells of children with autoimmune hepatitis," Archives of Virology volume 141, 1996, pages 877-884: "The measles virus is known to be persistent in patients with subacute sclerosing panencephalitis (SSPE) and measles inclusion body encephalitis (MIBE). Since the introduction of measles vaccines, vaccine-associated SSPE has increased in the USA. Therefore, we should pay attention to SSPE after inoculation with measles vaccine, despite the decrease in the incidence of [wild] measles."

"The African polio vaccine-acquired immune deficiency syndrome connection" (Medical Hypotheses, vol. 48, no. 5, May 1997, pp. 367-74): "Seroepidemiological, clinical and molecular findings suggest that the acquired immune deficiency syndrome virus Human Immunodeficiency Virus-1* was introduced into the human species at the the (late 1950s) and in the geographic area (Zaire) in which millions of Africans were vaccinated with attenuated poliomyelitis virus strains that were produced in kidney tissue obtained from monkeys. …it is reasonable to suspect that a then non-detectable monkey virus with human-1-like properties was unknowingly cocultured with the attenuated poliovirus and subsequently administered to the vaccinees. The possibility of such a polio vaccine-acquired immune deficiency syndrome connection is a reminder of the unpredictable danger of artifically crossing natural species-barriers in biomedical laboratories" [*bold text capitals added].

"The origin of HIV-1, the AIDS virus" (Medical Hypotheses, vol. 41, no. 4, October 1993, pp. 289-99): "a substantial case is presented that HIV-1 is a natural recombinant of Bovine Leukemia Virus (BLV) and Visna Virus. This natural recombinant may have been inadvertently transferred to humans through the Intensified Smallpox Eradication Program conducted in sub-Saharan Africa in the late 1960s and most of the 1970s."

"Simian cytomegalovirus-related stealth virus isolated from the cerebrospinal fluid of a patient with bipolar psychosis and acute encephalopathy" (Pathobiology , vo. 64, no. 2, 1996, pp. 64-6): a cytopathic 'stealth' virus was cultured from the cerebrospinal fluid of this patient, who developed a severe encephalopathy leading to a vegetative state. DNA sequencing of a polymerase chain reaction-amplified product from infected cultures revealed kinship to the African green monkey simian cytomegalovirus.

Disorders of the ear
Blood disorders
"Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine" (Archives of Disease in Childhood, vol. 78, no. 3, March 1998, pp. 273-4): Three cases of [auto]immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under six months of age. There were no other possible causes; defect in platelet production was excluded in two children. Antiplatelet antibodies were present. The babies were treated with corticosteroids.

Hepatitis
"Polymerase chain reaction detection of the hemagglutinin gene from an attenuated measles vaccine strain in the peripheral mononuclear cells of children with autoimmune hepatitis," Archives of Virology volume 141, 1996, pages 877-884: Four pediatric and two adults patients with autoimmune hepatitis were tested and followed in this study. Twelve healthy children served as controls, who had either been infected with measles or vaccinated with an attenuated measles vaccine in the past. All controls were negative for measles virus except a recent (two week) vaccinee. Of the hepatitis patients, all were positive for measles virus—the children with vaccine-strain measles virus, and the adults with different strains. Conclusion: "our results demonstrated that children with autoimmune hepatitis can have persistence of the vaccine strain in vivo for many years after vaccination [abstract, page 877]." The authors state that the persistence of the measles virus might play some role in the pathology of autoimmune hepatitis, but further studies are needed to prove this hypothesis (page 883).

Also in "Polymerase," the authors observe that high levels of serum antibodies to measles virus have been reported in patients with autoimmune hepatitis (p. 877). References add systemic lupus erythematosus and infectious mononucleosis to the tally of autoimmune diseases with connections to measles (pages 883-4). [Note: high antibody titers of measles and rubella are also associated with autism.] Some provocative quotes, page 882:

"Apparently, the attenuated vaccine is also capable of persisting, like sporadic wild strains, in certain immune diseases.
The measles virus is known to be persistent in patients with subacute sclerosing panencephalitis (SSPE) and measles inclusion body encephalitis (MIBE). Since the introduction of measles vaccines, vaccine-associated SSPE has increased in the USA. Therefore, we should pay attention to SSPE after inoculation with measles vaccine, despite the decrease in the incidence of [wild] measles."

[Note: the following study did not broach the subject of vaccine involvement in diseases; rather it serves to point out the relationship of viral presences to disease.] …Department of Virology, University of Helsinki, Finland, "Very high measles and rubella virus antibody titres associated with hepatitis, systemic lupus erythematosus, and infectious mononucleosis" (The Lancet, vol. 1, February 9, 1974, pp. 194-7): In patients without preceding rubella or measles infection, "raised levels of viral antibodies were a constant finding in two repeated analyses" of hepatitis patients. The authors felt that "it is conceivable that rubella and/or measles infections or reinfections may cause acute hepatitis and persist in some individuals…such aberrant virus infection might be responsible for some clinical manifestations….." Chronic virus infection could not be excluded as an important factor in these diseases.

Inflammatory and autoimmune bowel disease
"Paramyxovirus infections in childhood and subsequent inflammatory bowel disease" (Gastroenterology, vol. 116, no. 4, April 1999, pp. 796-803): "Measles virus has been implicated in the etiology of both inflammatory bowel diseases (IBDs), Crohn's disease and ulcerative colitis… Mumps infection before age 2 years was a risk for ulcerative colitis… Measles and mumps infections in the same year of life were significantly associated with ulcerative colitis and Crohn's disease…but not with IDDM… Atypical paramyxovirus infections in childhood may be risk factors for later I[nflammatory] B[owel] D[isease]" [Notes: measles-mumps-rubella vaccine is usually given around the age of 16 months. When vaccine viruses induce infection, it is often atypical in character].

Lupus, multiple sclerosis and rheumatoid arthritis
Abstract: autoimmune diseases are becoming increasingly common. The majority seem to have viral associations.

"Vaccine-induced autoimmunity" (Journal of Autoimmunity, vol. 9, no. 6, December 1996, pp. 699-703): the authors summarize of case reports attributing autoimmune diseases and autoimmune phenomena to vaccines, and suggest possible mechanisms by which the two could be related. "The subject is complicated," they say, "by the fact that one vaccine may cause more than one autoimmune phenomenon, and a particular immune process may be caused by more than one vaccine. Furthermore, vaccines differ in their pathogenic influence on the immune system... The subject of the vaccine-autoimmunity relationship is still obscure; reports have been rare, [and] no laboratory experimentation on this topic has been undertaken....." (Oddly, the authors state that the benefits of vaccination outweigh the risks of disease, but given the authors' contentions that vaccines can cause one or more types of autoimmune disease, that reports are few and research non-existent, this statement is unsupported. Further, they conclude that "laborious clinical and laboratory studies should be initiated in order to evaluate the ..subject.")

C. M. Poser, Harvard Medical School, "The pathogenesis of multiple sclerosis. Additional considerations" (Journal of Neurological Science, vol. 115, April 1993, Supplement pp. S3-15): "Multiple sclerosis is acquired as a systemic "trait" by individuals who are genetically susceptible…It develops as the result of an antigenic challenge by a viral protein, either from a viral infection or a vaccination."

"Multiple sclerosis and infectious childhood diseases" (Neuroepidemiology, vol. 17, no. 3, 1998, pp. 154-60): multiple sclerosis patients studied had had measles, mumps, and varicella (chicken pox) infections at a later age than healthy controls. "These results are compatible with the hypothesis that the risk of developing multiple sclerosis may be associated with acquiring certain infectious childhood diseases at a later state in comparison to normal controls." [Early vaccination for these diseases, therefore, may predispose vaccinees to MS, as immunity from vaccinations frequently wanes in the years following early childhood vaccination (unlike immunity to natural infection). In the event of such a vaccine failure, natural infection may occur at a later age.]

"Chronic arthritis after rubella vaccination" (Clin. Infectious Disease, vol. 15, no. 2, August 1992, pp. 307-312. After reviewing a wide range of information sources, The Institute of Medicine, Washington, DC, found a causal relationship between rubella vaccination and chronic arthritis in adult women.
--for lupus, see "cognitive disorders" below--

Parasthesias/paralytic and muscular diseases
"Drug Points: Transverse Myelitis After Measles, Mumps, and Rubella Vaccine," BMJ [British Medical Journal], vol. 311 (7002), August 12, 1995, p. 422: a twenty-year-old man was vaccinated against rubella with the MMR vaccine. Five days later he developed fever, malaise, sore throat, and a transient, upper-body rash. Within the next two weeks, he developed an ascending paraesthesia. He was hospitalized on developing a rapidly progressive flaccid paraplegia. Serological tests showed a significant rise in rubella antibodies. Postvaccination transverse myelitis was diagnosed.

"Poliovirus vaccine options" (American Family Physician, vol. 59, no. 1, January 1, 1999, pp. 113-8, 125-6): "Of 142 confirmed cases of paralytic poliomyelitis reported in the United States from 1980-1996, 134 were classified as vaccine-associated paralytic poliomyelitis (VAPP). Persons with VAPP have a disabling illness….."

"Demonstration of specific antineuronal nuclear antibodies in sera of patients with myasthenia gravis" (Neurology, vol. 24, no. 7, July 1974, pp. 680-3).

Other disorders of the brain and nervous system
Abstract: Vijendra K. Singh and others have found a significant association between autoimmune processes in autistic patients and viral presences--in particular, anti-myelin basic protein (anti-brain) antibodies, along with high titers of specific viruses. In this regard, see also "Demonstration of specific antineuronal nuclear antibodies," above, and the description of T. Zecca's report, "Elevated rubeola [measles] titers in autistic children linked to MMR vaccine," above.

Seizure disorders
"Autistic subjects with comorbid epilepsy: a possible association with viral infections" (Child Psychiatry and Human Development, vo. 29, no. 3, Spring 1998, pp. 245-51): Data covering a 30-year period was examined in Israel. The annual birth pattern of 290 autistic subjects with comorbid epilepsy fit the seasonality of viral meningitis. "These findings support the role of viral C[entral] N[ervous] S[ystem] infections in the causality of this disorder."

"Neurologic complications after vaccination against diphtheria, tetanus and whooping cough (Cesk. Pediatr., vol. 47, no. 2, February 1992, pp. 122-4): Both in children free from neurological disease and in children with neurological disease the most frequent type of complications from DTP vaccination were "encephalopathies and febrile attacks as a consequence of metabolic and toxic changes following vaccination." Persisting neurological disorders were, in the majority, epileptic in character.

"Vaccination against whooping-cough. Efficacy versus risks," The Lancet, vol. 1, January 29, 1977, pp. 234-7: "Adverse reactions and neurotoxicity following vaccination was strongly related to pertussis vaccine in 79 of 160 cases studied. A shock reaction and cerebral disturbance was seen, in most of these cases followed by

convulsions, hyperkinesis, and severe mental defect. The authors conclude, "It seems likely that most adverse reactions are unreported and that many are overlooked…existing provisions, national and international, for epidemiological surveillance and evaluation are inadequate. The claim by official bodies that the risks of whooping-cough exceed those of vaccination is questionable, at least in the U.K."

O. Tonz and S. Bajc, "Convulsions or status epilepticus in 11 infants after pertussis vaccination" (Schweiz. Med. Wochenschr., vol. 110, no. 51, December 20, 1980, pp. 1965-71): In three of 11 cases, grand mal epilepsy persisted and two children developed infantile epileptic encephalopathy (Lennox Syndrome). "The following conclusions are drawn from these observations: 1) In view of the usually benign course of whooping cough today, current vaccination is hardly satisfactory. Improvement of the available vaccines is an urgent necessity… 2) Parents whould be better informed about the risks involved in pertussis vaccination. 3) Booster inoculations should be abandoned. 4) Health authorities should decide whether the current pertussis vaccination program should be abandoned. 5) Complications following vaccination should be registered….."

Behavior and movement disorders
"A controlled study of serum anti-locus ceruleus antibodies in REM sleep behavior disorder" (Sleep, vol. 20, no. 5, May 1997, pp. 349-51): "The newly identified association of human nonnarcoleptic rapid eye movement (REM) sleep behavior disorder (RBD) with human leukocyte antigen (HLA) DQwl class II genes raises the possibility that RBD may arise from autoimmune mechanisms."

[The following reports are not vaccine-specific; rather they serve to underline one of the possible conditions resulting from altered permeability of, or damage to the intestine, as occurs in association with measles and other viruses. Note: strep-type bacteria are among those which can translocate from the gut; these have been implicated in cases of Obsessive-Compulsive Disorder and Tourette Syndrome.] "Bacterial translocation from the gastrointestinal tract" (Trends in Microbiology, vol. 3, no. 4, April 1995, pp. 149-54): Viable indigenous bacteria from the gastrointestinal tract can migrate to other sites within the body, such as the mesenteric-lymph-node complex, liver, spleen, and bloodstream. Three mechanisms support bacterial translocation: intestinal bacterial overgrowth, deficiencies in host immune defenses and increased permeability or damage to the intestinal mucosal barrier.

"Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome" (Journal of the American Academy of Child and Adolescent Psychiatry, vol. 34, no. 3, March 1995, pp. 307-11): the authors hypothesize that infections with group A beta-hemolytic streptococci, among other bacterial agents, may trigger autoimmune responses that cause or exacerbate some cases of childhood-onset obsessive-compulsive disorder (OCD) or tic disorders including Tourette's Syndrome. In this study, four boys aged 10 to 14 years presented with OCD or Tourette's Syndrome in the moderate to very severe range. Two had evidence of recent group A beta-hemolytic streptococci infections, and the others had histories of recent viral illnesses.

"Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood" (Pediatrics, vol. 93, no. 2, February 1994, pp. 323-6): "Several converging lines of evidence suggest that some behavioral and neurological abnormalities of childhood may be mediated through antineuronal antibodies. These antineuronal antibodies appear to arise in response to group A [beta]-hemolytic streptococcal (GABHS) infections and to cross-react with cells within the central nervous system (CNS). Based on clinical observations of children with Sydenham's chorea, Tourette's syndrome (TS), and/or obsessive-compulsive disorder (OCD), we hypothesize that neuroimmunological dysfunction secondary to antineuronal antibodies may result in behavioral disturbances, such as anxiety, emotional lability, obsessive compulsive symptoms, hyperactivity, and sleep disturbances, and neurological abnormalities, such as motor and phonic tics, ballismus, chorea, and choreiform movements."

"Antineuronal antibodies: tics and obsessive-compulsive symptoms" (Journal of Developmental and Behavioral Pediatrics, vol. 15, no. 6, December 1994, pp. 421-5): 19 or 38 cases from an ongoing study of childhood neurodevelopmental disordershad existing or previously docuemnted OCS [OCD] and attention-deficit hyperactivity disorder (ADHD), with or without concomitant tics. 19 controls had ADHD, but no tics or OCS. Evidence was found of basal ganglia involvement in OCS, and a generalized central nervous system response [to infection] was suggested.

"Bipolar disorders, dystonia, and compulsion after dysfunction of the cerebellum, dentatorubrothalamic tract, and substantia nigra" (Biological Psychiatry, vol. 40, no. 8, October 1996, pp. 726-30): the mechanism of the legions was not abstracted in this report; however, after focal cerebellar circuit lesions, these disorders presented in three of fifteen subjects.

"Antineuronal antibodies in movement disorders" (Pediatrics, vol. 92, no. 1, July 1993, pp. 39-43): 24 children with recent-onset movement disorders (Tourette Syndrome, motor and/or vocal tics, chorea, and choreiform movements) as well as ADHD, behavior disorders, or learning disabilities were studied. The authors concluded that their data strongly suggests an association between antecedent group A beta-streptococcal infection and serum antineuronal antibodies, which may, in turn, be linked to childhood movement disorders.

"Antibodies to human caudate nucleus neurons in Huntington's chorea" (Journal of Clinical Investigation, vol. 59, no. 5, May 1977, pp. 922-32): IgG antibodies against nervous system components were detected in patients afflicted with Huntington's and Parkinson's Diseases, as well as in asymptomatic spouses of patients. "These data may support an environmental or infectious factor somehow involved in the ultimate expression of HD."

[This report is not vaccine-specific, but underlines a radical shift in thinking about cerebral palsy and a variety of other neurological impairments--i.e., to an infectious etiology.] "Infections may underlie cerebral palsy" (Science News, vol. 154, no. 16, October 17, 1998, p. 244; available a
http://www.sciencenews.org/sn_arc98/10_17_98/fob1.htm :
"Most doctors have believed that cerebral palsy--a form of brain damage that impairs movements--results from a difficult birth… While asphyxia may indeed be a cause of cerbral palsy, a new study provides evidence that the brain damage might often arise from some other…assault on an unborn child. Molecular clues now lead to inflammatory infection as a possible culprit, says Karein B. Nelson, a pediatric neurologist at the National Institute of Neurological Disorders and Stroke in Bethesday, MD." A study was performed by Nelson and colleagues which compared blood from normal and CP infants: the team found that all the stricken children harbored greater concentrations of substances indicating immune activation. In some of the children, indications of autoimmunity were seen as well. (Study citation: "Neonatal cytokines and coagulation factors in children with cerebral palsy," Annals of Neurology, vol. 44, October 1998, p. 665.)

"Increased prevalence of antibrain antibodies in the sera from schizophrenic patients" (Schizophrenia Research, vol. 14, no. 1, December 1994, pp. 15-22); "Antibodies to brain tissue in sera of schizophrenic patients-preliminary findings" (European Archives of Psychiatry and Clinical Neuroscience, vol. 242, no. 5, 1993, pp. 314-7): Antibrain antibodies have been found in the sera of schizophrenic patients, but not in normal controls. These seem to be directed against brain centers affected in schizophrenia.

Cognitive disorders
"Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders" (Journal of Pediatrics, vol. 134, no. 5, May 1999, pp. 607-613): "Etiologically unexplained disorders of language and social development have often been reported to improve in patients treated with immune-modulating regimens. Here we determined…children with L[andau] K[leffner] S[ydrome] V[ariant] and A[utistic] S[pectrum] D[isorder] have a greater frequency of serum antibodies to brain endothelial cells and to nuclei than children with non-neurologic illnesses or healthy children. The presence of these antibodies raises the possibility that autoimmunity plays a role in the pathogenesis of language and social developmental abnormalities in a subset of children with these disorders.

"Characteristics of antineuronal antibodies in systemic lupus erythematosus patients with and without central nervous system involvement: the role of mycobacterial cross-reacting antigens" (Israeli Journal of Medical Science, vol. 26, no. 7, July 1990, pp. 367-73): indirect immunofluorescence of human brain tissue sections revealed, in thirteen of sixteen patients, high antineuronal antibody titers. Competition assays showed that the binding of the antineuronal antibodies was blocked by mycobacterial glycolipids and bovine brain extracts.

"This finding suggests an additional link between mycobacterial infection and SLE."
"An immunological approach to dementia in the elderly" (Age and Ageing, vol. 5, no. 3, August 1976, pp. 164-70): Immunofluorescence studies showed "an excess of antineuronal reactivity and a fall in antinuclear antibody in females with senile dementia."

Alteration of human genetic code
Abstract: viruses are able to infiltrate cells, inserting their genetic material into them. Indications have been found of changes to human genetic characteristics as a result of viral invasion.

There were no genetic or metabolic anomalies revealed during testing which might have explained the CNS symptoms.
 The viral encephalopathies which presented with or following vaccination were not due to transplacental viral infection. EEGs after initial symptoms were negative in 92 percent. Following vaccination and CNS symptoms, serologic investigations for herpes viruses were positive in all cases for IgG. IgG for Epstein-Barr virus and cytomegalovirus were estimated to be positive in 73.8/71.4 percent respectively, herpes simplex in 47.6 percent, and varicella zoster in 21.4 percent of patients. 73.3 percent of subjects showed an increase in the HLA-A3 and HLA-DR7 antigens as compared with the Italian population at large.

The authors found and describe, in this paper, biochemical markers of vaccine damage (e.g., changes in inherited HLA type). They also point out that most vaccines contain thimerosal, a toxic substance associated with neurologic and gastrointestinal symptoms. The fact that post-vaccinal pathologies of the central nervous system are often not thoroughly investigated occasioned this study. Additional cases are under study to better define the possible association of HLA A3 and/or HLA DR7 with this CNS pathology following vaccination.

"New Genetic Study Points Way for Vaccine Reaction Research/Novel Genetic Clinical Marker Found in Blood of Gulfwar Vets" (Press release, National Vaccine Information Center/PR Newswire, Washington, D.C., May 3, 1999, 5:48 p.m.; original source is Clinical and Diagnostic Laboratory Immunology, May 1999): A three year study funded and conducted by the Chronic Illness Research Foundation in collaboration with the University of Michigan School of Medicine found abnormal RNA in the blood of 50 percent of sick Gulf War veterans, indicating that chromosomal damage had occurred. This genetic material was not found in any of the healthy controls. Damage to chromosome 22q11.2 has been linked in other published studies to autoimmune diseases such as juvenile rheumatoid arthritis and other illnesses like multiple myeloma cancer.
The discovery of RNA in the cell-free fractions of blood is an anomaly, as it is not normally present in serum. RNA can exist outside the cell only if it is protected, as RNA viruses can. Gulf War soldiers were given 17 different viral and bacterial vaccines, including experimental anthrax and botulinum toxoid vaccines. Experimental drugs were also given and [in veterans actually deployed to the Gulf] there were exposures to pesticides, low-level chemical warfare agents, low-level radiation, toxic combustion products, etc. The resultant symptoms are similar to those of vaccine-damaged children.
Dr. Howard B. Urnovitz, microbiologist and Science Director of the Chronic Illness Research Foundation, interpreted findings to indicate that certain genotypes may be particularly at risk for sustaining chromosomal damage after exposure to toxic events; ways to identify and prescreen for individuals who may be at high risk for chromosomal damage should be found.

Many thanks to Laura J. Ruede who supplied the text and study details above  

http://lib.tcu.edu/www/staff/lruede/autvacc 

Vaccine Damage

Vaccine damage lawyers http://www.sarasotalaw.com/main.html  

http://www.geocities.com/Heartland/Flats/6997/lawyer.html

Hospital vaccine damage bulletin board

http://neurowww.mgh.harvard.edu/forum/VaccineorDTPinjuriesMenu.html

Vaccine Awareness Web Ring  http://www.geocities.com/Heartland/Flats/6997/home.html

Syphilis from smallpox vaccination (1880)

A Smallpox Vaccine Disaster Record (1855--1880)

Two pictures from the early part of the century:

Mrs Helen Goates of Bolivar, Missouri.   Cancer from vaccine.

Benjamin Olevine of Altoona, Pennsylvania.  Tumour developed from vaccine sore.

Tratto da: http://www.whale.to/vaccines/damaged.html

Continua in: Pag. 6  -  Pag. 7  -  Pag. 8  -  Pag. 9  -  Pag. 10  -  Pag 11  -  Pag. 12  -  Pag. 13  - Pag 14  - Pag 15  -
Pag. 16  -  Pag. 17  -  Pag. 18  -  Pag.19  -  Pag. 20  -  Pag. 21
vedi anche: Dati ISTAT sui Vaccini +  Statistiche Istat sui vaccini + Malattie e Vaccini +  Interrogazione Parlamentare + Contenuto dei vaccini + Falsita' della medicina ufficiale +  1000 studi sui Danni dei Vaccini

Consulenze e perizie per danni da vaccino dott.  M. Montinari     
Autismo, Vaccini, la prova -  Il libro ormai esaurito, del dott. Massimo Montinari
Gli anticorpi che dovrebbero essere indotti da un vaccino NON indicano immunità. Ciò che mette molti medici in confusione è che parte della reazione nei confronti del vaccino porta alla produzione di anticorpi. Ciò è falsamente considerato immunità.

vedi anche: Ruolo dei Vaccini nella Guerra del Golfo  +  Guerra del Golfo, Uranio o Vaccini ?  +  Militari Uranio e Vaccini  +  Come si producono i Vaccini

RICERCA Parole nel SITO

HOME

BACK